FY2025 EPS Estimate for Core Laboratories Reduced by Analyst

Core Laboratories Inc. (NYSE:CLB) – Stock analysts at Zacks Research cut their FY2025 EPS estimates for Core Laboratories in a research note issued to investors on Wednesday, December 4th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings of $1.00 per share for the year, down from their prior forecast of $1.07. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.25 EPS and Q3 2026 earnings at $0.30 EPS.

Other analysts have also issued reports about the stock. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup decreased their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $17.00.

Core Laboratories Price Performance

NYSE:CLB opened at $19.86 on Thursday. The company has a market capitalization of $932.43 million, a P/E ratio of 31.03, a P/E/G ratio of 1.39 and a beta of 2.35. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories has a 52 week low of $13.82 and a 52 week high of $25.13. The stock’s fifty day moving average is $19.59 and its two-hundred day moving average is $19.61.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04. The firm had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.22 EPS.

Institutional Trading of Core Laboratories

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Disciplined Growth Investors Inc. MN grew its holdings in shares of Core Laboratories by 446.8% in the second quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock valued at $90,508,000 after purchasing an additional 3,644,963 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in Core Laboratories by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company’s stock valued at $6,215,000 after buying an additional 34,149 shares during the period. Earnest Partners LLC grew its stake in shares of Core Laboratories by 6.3% in the second quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after acquiring an additional 195,756 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Core Laboratories in the second quarter worth $36,000. Finally, nVerses Capital LLC purchased a new stake in shares of Core Laboratories during the third quarter worth $48,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.20%. The ex-dividend date was Monday, November 4th. Core Laboratories’s dividend payout ratio is currently 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.